Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE AND FINANCING FEES

6 Months Ended

Jun. 30, 2024

NOTE 12: INTEREST EXPENSE AND FINANCING FEES

Interest expense and financing fees for the three and six-month periods ended June 30, 2024 and 2023 consisted of the following:


	Three-Month Periods Ended June 30,				Six-Month Periods Ended June 30,
($’s in thousands)	2024		2023		2024		2023
Interest payments on term loans and LOC	$	499	$	399	$	985	$	932
Amortization/Accretion		64		272		126		297
Imputed interest on acquired intangible assets		—		85		—		177
Total interest expense and financing fees	$	563	$	756	$	1,111	$	1,406